IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 252 filers reported holding IMMUNOMEDICS INC in Q4 2019. The put-call ratio across all filers is 0.50 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $51,487,000 | +446.7% | 605,510 | +127.9% | 0.15% | +425.0% |
| Q2 2020 | $9,417,000 | +5017.9% | 265,710 | +1811.6% | 0.03% | – |
| Q3 2019 | $184,000 | +7.0% | 13,900 | +12.1% | 0.00% | – |
| Q2 2019 | $172,000 | -88.3% | 12,400 | -82.4% | 0.00% | -100.0% |
| Q3 2018 | $1,471,000 | -72.2% | 70,600 | -68.5% | 0.00% | -71.4% |
| Q2 2018 | $5,300,000 | +10.8% | 223,900 | -31.6% | 0.01% | +7.7% |
| Q1 2018 | $4,783,000 | -12.4% | 327,400 | -3.1% | 0.01% | -13.3% |
| Q4 2017 | $5,462,000 | +16.4% | 338,000 | +0.7% | 0.02% | +15.4% |
| Q3 2017 | $4,692,000 | +306.6% | 335,595 | +156.8% | 0.01% | +225.0% |
| Q2 2017 | $1,154,000 | +491.8% | 130,700 | +332.8% | 0.00% | +300.0% |
| Q1 2017 | $195,000 | +124.1% | 30,200 | +28.0% | 0.00% | – |
| Q4 2016 | $87,000 | -28.7% | 23,600 | -7.5% | 0.00% | -100.0% |
| Q4 2014 | $122,000 | – | 25,510 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 4,373,178 | $371,851,000 | 55.73% |
| Avoro Capital Advisors LLC | 26,250,000 | $2,232,038,000 | 31.71% |
| Twin Securities, Inc. | 467,761 | $39,774,000 | 28.60% |
| Palo Alto Investors LP | 4,852,383 | $412,598,000 | 22.65% |
| Sand Grove Capital Management LLP | 470,000 | $39,964,000 | 21.19% |
| Beryl Capital Management LLC | 1,046,632 | $88,995,000 | 16.02% |
| Western Standard LLC | 158,065 | $13,440,000 | 15.26% |
| One68 Global Capital, LLC | 60,990 | $5,186,000 | 13.76% |
| First Light Asset Management, LLC | 1,577,880 | $134,167,000 | 13.75% |
| Boxer Capital, LLC | 4,500,000 | $382,635,000 | 13.22% |